Lipid apheresis in the treatment of patients with severe, refractory hypercholesterolemia.
D001781:Blood Component Removal / Q000009:adverse effects; D054598:Blue Cross Blue Shield Insurance Plans; D002986:Clinical Trials as Topic; D018795:Device Approval; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000150:complications / Q000235:genetics / Q000628:therapy*; D008055:Lipids / Q000097:blood*; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D008055:Lipids